Hospital-based use of thromboprophylaxis in patients with COVID-19

doi:10.1016/S0140-6736(20)30926-0

Comment

. 2020 May 2;395(10234):e75.

doi: 10.1016/S0140-6736(20)30926-0. Epub 2020 Apr 21.

Hospital-based use of thromboprophylaxis in patients with COVID-19

Alex C Spyropoulos¹, Walter Ageno², Elliot S Barnathan³

Affiliations

¹ Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Center for Health Innovation and Outcomes Research, Feinstein Institutes for Medical Research, Department of Medicine, Northwell Health at Lenox Hill Hospital, New York City, 10577 NY, USA. Electronic address: aspyropoul@northwell.edu.
² Department of Medicine and Surgery, University of Insubria, Varese, Italy.
³ Janssen Research and Development, Spring House, PA, USA.

PMID: 32330428
PMCID: PMC7173816
DOI: 10.1016/S0140-6736(20)30926-0

Comment

Hospital-based use of thromboprophylaxis in patients with COVID-19

Alex C Spyropoulos et al. Lancet. 2020.

. 2020 May 2;395(10234):e75.

doi: 10.1016/S0140-6736(20)30926-0. Epub 2020 Apr 21.

Authors

Alex C Spyropoulos¹, Walter Ageno², Elliot S Barnathan³

Affiliations

¹ Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Center for Health Innovation and Outcomes Research, Feinstein Institutes for Medical Research, Department of Medicine, Northwell Health at Lenox Hill Hospital, New York City, 10577 NY, USA. Electronic address: aspyropoul@northwell.edu.
² Department of Medicine and Surgery, University of Insubria, Varese, Italy.
³ Janssen Research and Development, Spring House, PA, USA.

PMID: 32330428
PMCID: PMC7173816
DOI: 10.1016/S0140-6736(20)30926-0

No abstract available

PubMed Disclaimer

Comment on

Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia.
Tang N, Li D, Wang X, Sun Z. Tang N, et al. J Thromb Haemost. 2020 Apr;18(4):844-847. doi: 10.1111/jth.14768. Epub 2020 Mar 13. J Thromb Haemost. 2020. PMID: 32073213 Free PMC article.

Cited by

Systematic review and meta-analysis of cell therapy for COVID-19: global clinical trial landscape, published safety/efficacy outcomes, cell product manufacturing and clinical delivery.
Couto PS, Al-Arawe N, Filgueiras IS, Fonseca DLM, Hinterseher I, Catar RA, Chinnadurai R, Bersenev A, Cabral-Marques O, Moll G, Verter F. Couto PS, et al. Front Immunol. 2023 Jun 21;14:1200180. doi: 10.3389/fimmu.2023.1200180. eCollection 2023. Front Immunol. 2023. PMID: 37415976 Free PMC article.
Predictors and mortality risk of venous thromboembolism in patients with COVID-19: systematic review and meta-analysis of observational studies.
Agarwal G, Hajra A, Chakraborty S, Patel N, Biswas S, Adler MK, Lavie CJ. Agarwal G, et al. Ther Adv Cardiovasc Dis. 2022 Jan-Dec;16:17539447221105013. doi: 10.1177/17539447221105013. Ther Adv Cardiovasc Dis. 2022. PMID: 35762736 Free PMC article.
Rotational thromboelastometry in patients with acute respiratory distress syndrome owing to coronavirus disease 2019: Is there a viscoelastic fingerprint and a role for predicting thrombosis?
Vasovic LV, Littlejohn J, Alqunaibit D, Dillard A, Qiu Y, Rand S, Bronstein M, Gibson CJ, Kelly AG, Lee C, Minneman JA, Narayan M, Shou J, Smith KE, Villegas CV, Winchell RJ, Cushing MM, Barie PS. Vasovic LV, et al. Surgery. 2022 Apr;171(4):1092-1099. doi: 10.1016/j.surg.2021.08.051. Epub 2021 Sep 9. Surgery. 2022. PMID: 35090739 Free PMC article.
Anticoagulation treatment for patients with coronavirus disease 2019 (COVID-19) and its clinical effectiveness in 2020: A meta-analysis study.
Ge J, Ma Y, Wu Z, Jin J, Sun X. Ge J, et al. Medicine (Baltimore). 2021 Nov 24;100(47):e27861. doi: 10.1097/MD.0000000000027861. Medicine (Baltimore). 2021. PMID: 34964754 Free PMC article.
Therapeutic Effectiveness and Safety of Repurposing Drugs for the Treatment of COVID-19: Position Standing in 2021.
Alam S, Kamal TB, Sarker MMR, Zhou JR, Rahman SMA, Mohamed IN. Alam S, et al. Front Pharmacol. 2021 Jun 14;12:659577. doi: 10.3389/fphar.2021.659577. eCollection 2021. Front Pharmacol. 2021. PMID: 34220503 Free PMC article. Review.

See all "Cited by" articles

References

1. Tang N, Li D, Wang X, Sun Z. Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia. J Thromb Haemost. 2020;18:844–847. - PMC - PubMed
1. Zhou F, Yu T, Du R. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395:1054–1062. - PMC - PubMed
1. Obi AT, Tignanelli CJ, Jacobs BN. Empirical systemic anticoagulation is associated with decreased venous thromboembolism in critically ill influenza A H1N1 acute respiratory distress syndrome patients. J Vasc Surg Venous Lymphat Disord. 2019;7:317–324. - PubMed
1. Kahn SR, Lim W, Dunn AS. Prevention of VTE in nonsurgical patients: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 2012;141(suppl):e195S–e226S. - PMC - PubMed
1. Cohoon KP, De Sanctis Y, Haskell L, McBane RD, Spiro TE. Rivaroxaban for thromboprophylaxis among patients recently hospitalized for acute infectious diseases: a subgroup analysis of the MAGELLAN study. J Thromb Haemost. 2018;16:1278–1287. - PubMed

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources

[1] Tang N, Li D, Wang X, Sun Z. Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia. J Thromb Haemost. 2020;18:844–847. - PMC - PubMed

[2] Tang N, Li D, Wang X, Sun Z. Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia. J Thromb Haemost. 2020;18:844–847. - PMC - PubMed

[3] Zhou F, Yu T, Du R. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395:1054–1062. - PMC - PubMed

[4] Zhou F, Yu T, Du R. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395:1054–1062. - PMC - PubMed

[5] Obi AT, Tignanelli CJ, Jacobs BN. Empirical systemic anticoagulation is associated with decreased venous thromboembolism in critically ill influenza A H1N1 acute respiratory distress syndrome patients. J Vasc Surg Venous Lymphat Disord. 2019;7:317–324. - PubMed

[6] Obi AT, Tignanelli CJ, Jacobs BN. Empirical systemic anticoagulation is associated with decreased venous thromboembolism in critically ill influenza A H1N1 acute respiratory distress syndrome patients. J Vasc Surg Venous Lymphat Disord. 2019;7:317–324. - PubMed

[7] Kahn SR, Lim W, Dunn AS. Prevention of VTE in nonsurgical patients: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 2012;141(suppl):e195S–e226S. - PMC - PubMed

[8] Kahn SR, Lim W, Dunn AS. Prevention of VTE in nonsurgical patients: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 2012;141(suppl):e195S–e226S. - PMC - PubMed

[9] Cohoon KP, De Sanctis Y, Haskell L, McBane RD, Spiro TE. Rivaroxaban for thromboprophylaxis among patients recently hospitalized for acute infectious diseases: a subgroup analysis of the MAGELLAN study. J Thromb Haemost. 2018;16:1278–1287. - PubMed

[10] Cohoon KP, De Sanctis Y, Haskell L, McBane RD, Spiro TE. Rivaroxaban for thromboprophylaxis among patients recently hospitalized for acute infectious diseases: a subgroup analysis of the MAGELLAN study. J Thromb Haemost. 2018;16:1278–1287. - PubMed

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Hospital-based use of thromboprophylaxis in patients with COVID-19

Affiliations

Hospital-based use of thromboprophylaxis in patients with COVID-19

Authors

Affiliations

Comment on

Similar articles

Cited by

References

Publication types

MeSH terms

Substances

LinkOut - more resources

Full Text Sources